Rare diseases
Investigational molecules
Locations
Back to Germany987 clinical trials in Heilbronn, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Talquetamab and Tocilizumab for Patients with Relapsed or Refractory Multiple Myeloma
GermanyStudy on the Effectiveness of Autogene Cevumeran in Patients with ctDNA Positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
GermanyStudy on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment
GermanyStudy on Atezolizumab with Platinum-Based Chemotherapy for Patients with Early-Stage Resectable Non-Small Cell Lung Cancer
GermanyStudy Comparing Nivolumab and Ipilimumab with Chemotherapy to Chemotherapy Alone for Patients with Stage IV Non-Small Cell Lung Cancer
GermanyStudy on Aficamten for Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
GermanyStudy on the Safety and Effectiveness of Inhaled Imatinib (AV-101) for Patients with Pulmonary Arterial Hypertension (PAH)
GermanyStudy of XXB750 and Drug Combination for Patients with Heart Failure
GermanyStudy on the Effectiveness and Safety of allo-APZ2-CVU for Healing Chronic Venous Ulcers in Patients with Therapy-Resistant Wounds
GermanyStudy on Vericiguat for Children with Heart Failure from Left Ventricular Systolic Dysfunction
GermanyStudy of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
GermanyStudy on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on Acute Myeloid Leukemia (AML) and Chronic Lymphocytic Leukemia, testing novel drug combinations to improve patient outcomes. Research includes evaluating treatments for both adult and pediatric patients with various forms of leukemia.
Studies aim to enhance survival rates and develop more effective treatment strategies for blood cancer patients.
Comprehensive studies addressing different types of breast cancer, particularly focusing on triple-negative breast cancer and HER2-positive disease. Research includes both early-stage and metastatic disease treatments.
Trials evaluate novel drug combinations and targeted therapies to improve patient outcomes.
Research focusing on various digestive system cancers, including gastric cancer, colorectal cancer, and pancreatic cancer. Studies evaluate both early-stage and advanced disease treatments.
Investigations aim to improve surgical outcomes and treatment effectiveness for GI cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
